Slobodanka Ostojić Kolonić

University of Zagreb — Croatia

Medicine · Health Sciences

9h-index276citations169works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(51), Chronic Lymphocytic Leukemia Research(31), Lung Cancer Treatments and Mutations(13), Multiple Myeloma Research and Treatments(13), Myeloproliferative Neoplasms: Diagnosis and Treatment(13)

Publications169 total

Biomarkers Affecting Treatment Outcomes of Febrile Neutropenia in Hematological Patients with Lymphomas: Is Presepsin the New Promising Diagnostic and Prognostic Biomarker?
Journal of Clinical Medicine·2025· 2 citedOpen Access
Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins’s Lymphoma Patients—A Single Centre Experience
Cancers·2024· 1 citedOpen Access
First-Line Therapy for Nodal T-cell Non-Hodgkin Lymphomas: an Unmet Need in Hematology
Current Oncology Reports·2023· 1 cited
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience
La radiologia medica·2023· 3 cited
Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review
Biomedicines·2022· 1 citedOpen Access
CD4+/CD57+/CD69+ T lymphocytes and CD14+ dendritic cells accumulate in advanced follicular lymphoma
Immunobiology·2022· 2 cited
Macrophage Infiltration Correlates with Genomic Instability in Classic Hodgkin Lymphoma
Biomedicines·2022· 5 citedOpen Access
Purine Analogues Increase the Risk of Lethal and/or Prolonged COVID19 While Obinutuzumab Increases the Risk of Prolonged but Not Lethal Infection in Patients Treated for Lymphoid Malignancies -a Study of Krohem, the Croatian Group for Hematologic Diseases
Blood·2021· 2 citedOpen Access
The fading star of obinutuzumab-chlorambucil regimen in patients with comorbidities with chronic lymphocytic leukemia – are we ready for chemo-free immunotherapy approach?
Expert Review of Hematology·2020· 3 cited
DETERMINANTS OF QUALITY OF LIFE IN MULTIPLE MYELOMA PATIENTS: CROATIAN EXPERIENCE
2020Open Access
MICRORNA 99B AND LET7A AS DIAGNOSTIC PARAMETERS IN MYELODYSPLASTIC SYNDROME
HemaSphere·2020Open Access
MYELODYSPLASTIC SYNDROME IN A PATIENT WITH UNTREATED CHRONIC LYMPHOPROLIFERATIVE NEOPLASM
Liječnički vjesnik·2019Open Access
Neoangiogenesis andmicrovascular density in myelodysplastic syndrome – a single center experience
Molecular and experimental biology in medicine·2019Open Access
FDA's and EMA's approval of brentuximab vedotin for advanced Hodgkin lymphoma: Another player in the town?
European Journal Of Haematology·2019· 12 citedOpen Access
PB1907 IBRUTINIB THERAPY IS ASSOCIATED WITH SERIOUS INFECTIONS IN PATIENTS WITH B‐CELL MALIGNANCIES ‐ A SINGLE CENTER EXPERIENCE
HemaSphere·2019Open Access
Diagnostic utility of multiparameter flow cytometric immunophenotyping in multiple myeloma
Clinica Chimica Acta·2019
Croatian Hematology Society and CROHEM guidelines for the treatment of iron deficiency anemia
Liječnički vjesnik·2019· 2 citedOpen Access
[GUIDELINES FOR DIAGNOSIS AND TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROME].
PubMed·2019
MYELODYSPLASTIC SYNDROMES – NEW DISCOVERIES AND AN “OLD” MORPHOLOGY
Liječnički vjesnik·2019Open Access
MORPHOLOGY OF MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS (MDS/MPN)
Liječnički vjesnik·2019Open Access
page 1 of 9Next →

Frequent Co-authors

Ana Planinc‐Peraica(20), Ika Kardum‐Skelin(17), Inga Mandac Rogulj(16), Delfa Radić-Krišto(16), Branimir Jakšić(15), Vibor Milunović(11), Hrvoje Minigo(6), Marko Martinović(6), Ozren Jakšić(5), Rajko Kušec(5), Karla Mišura Jakobac(5), Martina Bogeljić Patekar(5), Slavko Gašparov(5), Radovan Vrḫovac(5), Igor Aurer(5), Zoran Šiftar(5), Mara Dominis(4), Gordana Kaić(4), Delfa Radić Krišto(4), Biljana Jelić Puškarić(4)